title: Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
authors.affiliation: Institute for Medical Oncology, University of Bern, Inselspital, Switzerland.
authors.forename: R A
authors.initials: RA
authors.lastname: Joss
authors.forename: S
authors.initials: S
authors.lastname: Monfardini
authors.forename: M
authors.initials: M
authors.lastname: Hansen
authors.forename: P
authors.initials: P
authors.lastname: Dombernowsky
authors.forename: J
authors.initials: J
authors.lastname: Renard
authors.forename: H M
authors.initials: HM
authors.lastname: Pinedo
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003630:Daunorubicin / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D017290:Menogaril; D008875:Middle Aged; D009621:Nogalamycin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D017290:Menogaril; D009621:Nogalamycin; D003630:Daunorubicin